חבר/ת סגל קליני
Faculty of Health Sciences, Internal Medicine Division
Dr. David Yardeni
Departments
Staff member contact section
Publications
Selected publications:
1. Yardeni D, Chang KM, Ghany MG.
Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure.
Gastroenterology. 2023; 164:42-60
2. Yardeni D, Cividalli O, Itkowitz B, Lipnizkiy I, Abu Juma'a A, Abufreha N, Keren-Naus A, Eisner N, Nevo Shor A, Etzion O.
Impact of Universal Screening for HDV in HBV-Infected Patients on Chronic HDV Detection Rate in Israel.
J Viral Hepat. 2025 Jul;32(7):e70046.
3. Yardeni D, Shiloh A, Lipnizkiy I, Nevo-Shor A, AbuFreha N, Munteanu D, Novack V, Etzion O.
MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Sci Rep. 2023 Dec; 13(1):22113
1. Yardeni D, Chang KM, Ghany MG.
Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure.
Gastroenterology. 2023; 164:42-60
2. Yardeni D, Cividalli O, Itkowitz B, Lipnizkiy I, Abu Juma'a A, Abufreha N, Keren-Naus A, Eisner N, Nevo Shor A, Etzion O.
Impact of Universal Screening for HDV in HBV-Infected Patients on Chronic HDV Detection Rate in Israel.
J Viral Hepat. 2025 Jul;32(7):e70046.
3. Yardeni D, Shiloh A, Lipnizkiy I, Nevo-Shor A, AbuFreha N, Munteanu D, Novack V, Etzion O.
MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Sci Rep. 2023 Dec; 13(1):22113
